-
公开(公告)号:US20060166989A1
公开(公告)日:2006-07-27
申请号:US10517677
申请日:2003-05-30
申请人: Makoto Shimazaki , Osamu Sakurai , Toshiki Murata , Klaus Urbahns , Noriyuki Yamamoto , Satoru Yoshikawa , Masaomi Umeda , Masaomi Tajimi , Tsutomu Masuda , Takuya Shintani , Haruka Shimizu
发明人: Makoto Shimazaki , Osamu Sakurai , Toshiki Murata , Klaus Urbahns , Noriyuki Yamamoto , Satoru Yoshikawa , Masaomi Umeda , Masaomi Tajimi , Tsutomu Masuda , Takuya Shintani , Haruka Shimizu
IPC分类号: A61K31/537 , A61K31/44 , A61K31/195 , C07D213/55 , C07D265/30 , C07C237/40
CPC分类号: C07C235/66
摘要: The present invention relates to 2-naphthamides, which are useful as an active ingredient of pharmaceutical preparations. The 2-naphthamides of the present invention have IP receptor antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with IP receptor activity. Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benign prostatic hypertrophy (BPH), pro-statitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity. The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension; hemophilia and hemorrhage; and inflammation, since the disease is also alleviated by treatment with an IP receptor antagonist.
摘要翻译: 本发明涉及可用作药物制剂活性成分的2-萘甲酰胺。 本发明的2-萘甲酰胺具有IP受体拮抗活性,可用于预防和治疗与IP受体活性相关的疾病。 这些疾病包括尿路疾病或病症如下:膀胱出口阻塞,膀胱过度活动,尿失禁,逼尿肌反射反射,逼尿肌不稳定,膀胱容量减少,排尿频率,急迫性尿失禁,压力性尿失禁,膀胱高反应性,良性前列腺肥大 ),pro-statitis,尿频,夜尿症,尿急,盆腔超敏反应,尿道炎,盆腔疼痛综合征,前列腺增生症,膀胱炎或自发性膀胱过敏反应。 本发明的化合物还可用于治疗疼痛,包括但不限于炎性疼痛,神经性疼痛,急性疼痛,慢性疼痛,牙痛,经前痛,内脏痛,头痛等; 低血压 血友病和出血; 和炎症,因为该疾病也通过用IP受体拮抗剂治疗而缓解。
-
公开(公告)号:US20060135613A1
公开(公告)日:2006-06-22
申请号:US10517646
申请日:2003-06-12
申请人: Makoto Shimazaki , Osamu Sakurai , Kanako Hirai , Klaus Urbahns , Noriyuki Yamamoto , Satoru Yoshikawa , Masaomi Umeda , Masaomi Tajimi
发明人: Makoto Shimazaki , Osamu Sakurai , Kanako Hirai , Klaus Urbahns , Noriyuki Yamamoto , Satoru Yoshikawa , Masaomi Umeda , Masaomi Tajimi
IPC分类号: A61K31/198 , A61K31/195 , C07C237/38
CPC分类号: C07C235/34
摘要: The present invention relates to carboxamides which are useful as an active ingredient of pharmaceutical preparations. The carboxamides of the present invention have IP receptor antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with IP receptor antagonistic activity. Such diseases include urological diseases or disorder as follows: bladder outlet obstruction, overactive bladder, urinary incontinence, detrusor hyper-reflexia, detrusor instability, reduced bladder capacity, frequency of micturition, urge incontinence, stress incontinence, bladder hyperreactivity, benighn prostatic hypertrophy (BPH), prostatitis, urinary frequency, nocturia, urinary urgency, pelvic hypersensitivity, urethritis, pelvic pain syndrome, prostatodynia, cystitis, or idiophatic bladder hypersensitivity. The compounds of the present invention are also useful for treatment of pain including, but not limited to inflammatory pain, neuropathic pain, acute pain, chronic pain, dental pain, premenstrual pain, visceral pain, headaches, and the like; hypotension; hemophilia and hemorrhage; and inflammation, since the diseases are alleviated by treatment with an IP receptor antagonist.
摘要翻译: 本发明涉及可用作药物制剂活性成分的羧酰胺。 本发明的甲酰胺具有IP受体拮抗活性,可用于预防和治疗与IP受体拮抗活性相关的疾病。 这些疾病包括泌尿系统疾病或紊乱,如下:膀胱出口阻塞,膀胱过度活动,尿失禁,逼尿肌反射反射,逼尿肌不稳定,膀胱容量减少,排尿频率,急迫性尿失禁,压力性尿失禁,膀胱反应过度,前列腺肥大 ),前列腺炎,尿频,夜尿症,尿急,盆腔超敏反应,尿道炎,盆腔疼痛综合征,前列腺痛,膀胱炎或自发性膀胱过敏。 本发明的化合物还可用于治疗疼痛,包括但不限于炎性疼痛,神经性疼痛,急性疼痛,慢性疼痛,牙痛,经前痛,内脏痛,头痛等; 低血压 血友病和出血; 和炎症,因为通过用IP受体拮抗剂治疗来减轻疾病。
-
公开(公告)号:US08173841B2
公开(公告)日:2012-05-08
申请号:US13052482
申请日:2011-03-21
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: C07C273/00 , A61K31/17
CPC分类号: C07D295/088 , C07C233/29 , C07C233/75 , C07C235/42 , C07C237/40 , C07C275/32 , C07C275/38 , C07C275/40 , C07C275/42 , C07C317/32 , C07C323/44 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontinence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及可用作药物制剂活性成分的四氢萘衍生物及其盐。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,膀胱过度活动症,急迫性尿失禁,慢性疼痛,神经性疼痛 ,手术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。
-
公开(公告)号:US20110178088A1
公开(公告)日:2011-07-21
申请号:US13052482
申请日:2011-03-21
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/17 , C07C275/28 , C07C229/52 , A61K31/216 , A61K31/192 , C07D295/18 , A61K31/5375 , C07D211/06 , A61K31/445 , C07C233/64 , A61P13/10 , A61P13/02 , A61P29/00 , A61P25/00 , A61P11/00
CPC分类号: C07D295/088 , C07C233/29 , C07C233/75 , C07C235/42 , C07C237/40 , C07C275/32 , C07C275/38 , C07C275/40 , C07C275/42 , C07C317/32 , C07C323/44 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontinence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及可用作药物制剂活性成分的四氢萘衍生物及其盐。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,膀胱过度活动症,急迫性尿失禁,慢性疼痛,神经性疼痛 ,手术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。
-
公开(公告)号:US07612113B2
公开(公告)日:2009-11-03
申请号:US10513848
申请日:2003-04-28
申请人: Takeshi Yura , Muneto Mogi , Klaus Urbahns , Hiroshi Fujishima , Tsutomu Masuda , Toshiya Moriwaki , Nagahiro Yoshida , Toshio Kokubo , Masahiro Shiroo , Masaomi Tajimi , Yasuhiro Tsukimi , Noriyuki Yamamoto
发明人: Takeshi Yura , Muneto Mogi , Klaus Urbahns , Hiroshi Fujishima , Tsutomu Masuda , Toshiya Moriwaki , Nagahiro Yoshida , Toshio Kokubo , Masahiro Shiroo , Masaomi Tajimi , Yasuhiro Tsukimi , Noriyuki Yamamoto
IPC分类号: A61K31/17 , C07C275/30 , C07C275/32
CPC分类号: C07C275/42 , C07C275/32 , C07C275/40
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have an excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, incontinence, inflammatory disorders such as asthma and COPD.
摘要翻译: 本发明涉及四氢萘衍生物及其盐,其可用作药物制剂的活性成分。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗急性尿失禁,膀胱过度活动症,慢性疼痛,神经性疼痛,术后 疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,失禁,炎症性疾病如哮喘和COPD。
-
6.
公开(公告)号:US20090209514A1
公开(公告)日:2009-08-20
申请号:US12432600
申请日:2009-04-29
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/55 , A61K31/4453 , A61K31/5375 , A61P13/00
CPC分类号: C07C275/32 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The tetrahydronaphthalene derivatives of the present invention have an excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及四氢萘衍生物及其盐,其可用作药物制剂的活性成分。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,敦促尿失禁,膀胱过度活动症,慢性疼痛,神经性疼痛, 术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。
-
公开(公告)号:US20060128704A1
公开(公告)日:2006-06-15
申请号:US10537482
申请日:2003-11-28
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/537 , A61K31/277 , A61K31/165 , A61K31/17
CPC分类号: C07D295/088 , C07C233/29 , C07C233/75 , C07C235/42 , C07C237/40 , C07C275/32 , C07C275/38 , C07C275/40 , C07C275/42 , C07C317/32 , C07C323/44 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as active ingredients of pharmaceutical preparations. They have the general formula (I) in which R1 represents hydrogen or C1-6 alkyl, and X represents —N(H)Y1, —N(H)—C1-6 alkylene Y1, biphenyl or C1-6 alkyl substituted by biphenyl, and the group Y1 is an optionally substituted biphenyl. The tetrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonists and are useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontinence, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及四氢萘衍生物及其盐,其可用作药物制剂的活性成分。 它们具有其中R 1表示氢或C 1-6烷基的通式(I),X表示-N(H)Y 1, -O(H)-C 1-6亚烷基Y 1,被联苯取代的联苯基或C 1-6烷基,和 基团Y 1是任选取代的联苯。 本发明的四氢 - 萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,膀胱过度活动症,急迫性尿失禁,慢性疼痛,神经性 疼痛,术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎性疾病,哮喘和COPD。
-
公开(公告)号:US08088826B2
公开(公告)日:2012-01-03
申请号:US12103396
申请日:2008-04-15
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/17
CPC分类号: C07D295/088 , C07C233/29 , C07C233/75 , C07C235/42 , C07C237/40 , C07C275/32 , C07C275/38 , C07C275/40 , C07C275/42 , C07C317/32 , C07C323/44 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-Naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tethrahydro—Naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontienence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及四氢萘衍生物及其盐,其可用作药物制剂的活性成分。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,膀胱过度活动症,敦促性尿失禁,慢性疼痛,神经性疼痛 ,手术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。
-
公开(公告)号:US20080275047A1
公开(公告)日:2008-11-06
申请号:US12103396
申请日:2008-04-15
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/5375 , A61K31/17 , A61P13/00 , A61K31/167
CPC分类号: C07D295/088 , C07C233/29 , C07C233/75 , C07C235/42 , C07C237/40 , C07C275/32 , C07C275/38 , C07C275/40 , C07C275/42 , C07C317/32 , C07C323/44 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives and salts thereof which are useful as an active ingredient of pharmaceutical preparations. The tethrahydro-naphthalene derivatives of the present invention have excellent activity as VR1 antagonist and useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, overactive bladder, urge urinary incontienence, chronic pain, neuropathic pain, post-operative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD.
摘要翻译: 本发明涉及可用作药物制剂活性成分的四氢萘衍生物及其盐。 本发明的四氢萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性有关的疾病,特别是用于治疗尿失禁,膀胱过度活动症,敦促性尿失禁,慢性疼痛,神经性疼痛 ,手术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。
-
10.
公开(公告)号:US07544716B2
公开(公告)日:2009-06-09
申请号:US10537217
申请日:2003-11-28
申请人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
发明人: Masaomi Tajimi , Toshio Kokubo , Masahiro Shiroo , Yasuhiro Tsukimi , Takeshi Yura , Klaus Urbahns , Noriyuki Yamamoto , Muneto Mogi , Hiroshi Fujishima , Tsutomu Masuda , Nagahiro Yoshida , Toshiya Moriwaki
IPC分类号: A61K31/17
CPC分类号: C07C275/32 , C07C2602/10 , C07D207/27 , C07D211/22 , C07D211/46 , C07D211/62 , C07D295/135
摘要: This invention relates to tetrahydro-naphthalene derivatives of formula (I) in which the variable groups are as defined in the specification and claims, and tautomeric and stereoisomeric forms and salts thereof which are useful as active ingredients of pharmaceutical preparations. The tetrahydro-naphthalene derivatives of the present invention have an excellent activity as VR1 antagonists and are useful for the prophylaxis and treatment of diseases associated with VR1 activity, in particular for the treatment of urinary incontinence, urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, algesia, nerve injury, ischaemia, neurodegeneration, stroke, inflammatory disorders, asthma and COPD. The compounds, pharmaceutical compositions containing them, and methods of treatment using them are disclosed and claimed.
摘要翻译: 本发明涉及式(I)的四氢 - 萘衍生物,其中可变基团如说明书和权利要求中所定义,以及其可用作药物制剂活性成分的互变异构体和立体异构形式及其盐。 本发明的四氢 - 萘衍生物作为VR1拮抗剂具有优异的活性,可用于预防和治疗与VR1活性相关的疾病,特别是用于治疗尿失禁,敦促性尿失禁,膀胱过度活动症,慢性疼痛, 神经性疼痛,术后疼痛,类风湿性关节炎疼痛,神经痛,神经病,痛觉,神经损伤,局部缺血,神经变性,中风,炎症性疾病,哮喘和COPD。 公开并要求保护所述化合物,含有它们的药物组合物和使用它们的治疗方法。
-
-
-
-
-
-
-
-
-